Bellerophon Therapeutics, Inc.

549300AH7DX6B7JBAP68

The entity

Status: Active
LEI status: Lapsed - not renewed
Category: Company
Legal form: Corporation (XTIQ)
Jurisdiction: US-DE
Entity created: October 17, 2013

Address

Country: United States
Legal address: C/O CORPORATION SERVICE COMPANY, 251 LITTLE FALLS DRIVE19808 WILMINGTONUnited States (US-DE)
Head office: 184 Liberty Corner Road, Suite 30207059 WarrenUnited States (US-NJ)

Identifier

LEI: 549300AH7DX6B7JBAP68
Registered: November 23, 2016 at 01:48 AM UTC
Last updated: July 22, 2026 at 01:28 PM UTC
Next renewal: November 21, 2017 at 09:20 PM UTC
Issuer: Bloomberg (5493001KJTIIGC8Y1R12)
Registered with: Division of Corporations, Department of State (RA000602)
Identifier: 5416869
Verified against: Division of Corporations, Department of State (RA000602)
Verified as: 5416869
Corroboration: Confirmed against a public register
GLEIF conformity: Does not meet the standard

Corporate structure

Why no parent is reported

No direct parent reportedNo ultimate parent reported: No parent prepares consolidated accounts including it

Machine access

REST: https://lei.online/v1/entities/549300AH7DX6B7JBAP68This record as JSON.
MCP: https://lei.online/mcpThe same data as an MCP tool.

Start a new search